Growing community of inventors

Rehovot, Israel

Nadège Gaborit

Average Co-Inventor Count = 3.58

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 4

Nadège GaboritYosef Yarden (2 patents)Nadège GaboritChristel Larbouret (2 patents)Nadège GaboritAndre Pelegrin (2 patents)Nadège GaboritThierry Chardes (2 patents)Nadège GaboritAndré Pelegrin (7 patents)Nadège GaboritMoshit Lindzen (1 patent)Nadège GaboritYassamine Lazrek (1 patent)Nadège GaboritMaicol Mancini (1 patent)Nadège GaboritThierry Chardes (1 patent)Nadège GaboritChristel Larbouret (1 patent)Nadège GaboritAndre Pelegrin (1 patent)Nadège GaboritNadège Gaborit (4 patents)Yosef YardenYosef Yarden (14 patents)Christel LarbouretChristel Larbouret (9 patents)Andre PelegrinAndre Pelegrin (8 patents)Thierry ChardesThierry Chardes (7 patents)André PelegrinAndré Pelegrin (7 patents)Moshit LindzenMoshit Lindzen (3 patents)Yassamine LazrekYassamine Lazrek (2 patents)Maicol ManciniMaicol Mancini (1 patent)Thierry ChardesThierry Chardes (2 patents)Christel LarbouretChristel Larbouret (2 patents)Andre PelegrinAndre Pelegrin (4 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Institut National De La Sante Et De La Recherche Medicale (2 from 1,743 patents)

2. Yeda Research and Develpment & Co. Ltd (2 from 1,168 patents)

3. Universitè De Montpellier (2 from 278 patents)

4. Institut Regional Du Cancer De Montpellier (1 from 14 patents)

5. Centre Val D'aurelle—paul Lamarque (1 from 1 patent)

6. Inserm (institut National De La Sante Et De La Recherche Medicale) (36 patents)

7. Inserm (0 patent)

8. Université De Montpellier 1 (0 patent)


4 patents:

1. 10526416 - Anti-HER3 antibodies and uses of same

2. 10196455 - Neuregulin allosteric anti-HER3 antibody

3. 10011659 - Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)

4. 9127065 - Anti-human HER3 antibodies and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/7/2025
Loading…